Please login to the form below

Not currently logged in
Email:
Password:

NKTR-102

This page shows the latest NKTR-102 news and features for those working in and with pharma, biotech and healthcare.

Nektar hit by breast cancer trial setback

Nektar hit by breast cancer trial setback

The development is also particularly disappointing for Nektar as NKTR-102 was a wholly owned project. ... Nektar said it would explore with regulators in the US and EU whether there is still a route to market for NKTR-102.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics